APA (7th ed.) Citation

SM, L., LR, H., JW, C., J, Z., RC, N., XH, J., . . . D, X. (2020). JMJD3 promotes esophageal squamous cell carcinoma pathogenesis through epigenetic regulation of MYC. Signal transduction and targeted therapy, 5(1), 165. https://doi.org/10.1038/s41392-020-00282-9

Chicago Style (17th ed.) Citation

SM, Li, et al. "JMJD3 Promotes Esophageal Squamous Cell Carcinoma Pathogenesis Through Epigenetic Regulation of MYC." Signal Transduction and Targeted Therapy 5, no. 1 (2020): 165. https://doi.org/10.1038/s41392-020-00282-9.

MLA (9th ed.) Citation

SM, Li, et al. "JMJD3 Promotes Esophageal Squamous Cell Carcinoma Pathogenesis Through Epigenetic Regulation of MYC." Signal Transduction and Targeted Therapy, vol. 5, no. 1, 2020, p. 165, https://doi.org/10.1038/s41392-020-00282-9.